Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents

NCT02684708 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2921

Enrollment

OTHER

Sponsor class

Conditions

Classical Hodgkin Lymphoma

Interventions

DRUG: cyclophosphamide, vincristine, prednisone, dacarbazine
DRUG: cyclo, vcr, pred, dacarb,etop and doxo

Sponsor

University of Giessen

Collaborators

[object Object]
[object Object]